Your session is about to expire
← Back to Search
Endoscopic Mucosal Resection
Cold vs Hot Snare EMR for Colonic Polyps (LPS-II Trial)
N/A
Waitlist Available
Research Sponsored by White River Junction Veterans Affairs Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with a ≥20mm non-pedunculated colorectal polyp
Be older than 18 years old
Must not have
Patients with inflammatory bowel disease
Patients with ulcerated depressed lesions (as defined by Paris Classification type III) or confirmed adenocarcinoma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at surveillance colonoscopies up to 5 years following the initial polyp resection
Summary
This trial is testing two methods of removing large colon growths, one using heat and one without. It also compares two different solutions to make the removal easier. The study focuses on patients with large colon polyps because these are harder to remove and have more risks. The goal is to find out which method and solution are safer and more effective.
Who is the study for?
This trial is for adults with large non-pedunculated colorectal polyps (≥20mm) who are undergoing a colonoscopy and have good general health. It's not for those with poor health, inadequate bowel prep, pedunculated or ulcerated depressed lesions, suspected deep cancer invasion, pregnancy, emergency procedures, coagulopathy or inflammatory bowel disease.
What is being tested?
The study compares two EMR techniques for removing large colorectal polyps: 'hot' snare using electrocautery and 'cold' snare without it. Additionally, it tests Eleview injection versus a placebo solution to see which is more effective in aiding the removal of these polyps.
What are the potential side effects?
Potential side effects may include bleeding or perforation of the colon from the resection procedure. There might also be reactions to the submucosal injections such as local irritation or allergic reaction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a large colorectal polyp that is not on a stalk.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have inflammatory bowel disease.
Select...
I have ulcerated lesions or confirmed adenocarcinoma.
Select...
I am undergoing an emergency colonoscopy.
Select...
My overall health is poor.
Select...
My cancer is suspected to be deep within the lining of an organ.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at surveillance colonoscopies up to 5 years following the initial polyp resection
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at surveillance colonoscopies up to 5 years following the initial polyp resection
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Severe Adverse Events
Secondary study objectives
Completeness of polyp resection
Crossover from cold to hot snare
Efficacy of submucosal injectate
+5 moreTrial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Cold snare & Eleview injectionExperimental Treatment2 Interventions
Polyp resection without electrocautery (cold snare EMR), and initial submucosal injection with Eleview
Group II: Cold Snare & Placebo injectionExperimental Treatment2 Interventions
Polyp resection without electrocautery (cold snare EMR), and initial submucosal injection with Placebo
Group III: Hot snare & Placebo injectionActive Control2 Interventions
Polyp resection with electrocautery (hot snare EMR), and initial submucosal injection with Placebo
Group IV: Hot snare & Eleview injectionActive Control2 Interventions
Polyp resection with electrocautery (hot snare EMR), and initial submucosal injection with Eleview
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo injection
2016
Completed Phase 4
~4080
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Electrocautery (Hot Snare EMR) uses electrical current to cut and coagulate tissue, allowing for precise removal of colorectal adenomas while minimizing bleeding. Eleview, a submucosal injection agent, is used to elevate the polyp, making it easier to resect and reducing the risk of perforation.
These mechanisms are important for colorectal adenoma patients as they enhance the safety and efficacy of polyp removal, reducing recurrence rates and improving long-term outcomes.
Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study.
Electrochemotherapy for colorectal cancer using endoscopic electroporation: a phase 1 clinical study.
Find a Location
Who is running the clinical trial?
SterisUNKNOWN
Cosmo PharmaceuticalsUNKNOWN
White River Junction Veterans Affairs Medical CenterLead Sponsor
31 Previous Clinical Trials
16,929 Total Patients Enrolled
1 Trials studying Colorectal Adenomas
1,500 Patients Enrolled for Colorectal Adenomas
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have inflammatory bowel disease.I am 18 or older and eligible for a colonoscopy without any exclusion criteria.I have ulcerated lesions or confirmed adenocarcinoma.I am undergoing an emergency colonoscopy.My overall health is poor.You are pregnant.My cancer is suspected to be deep within the lining of an organ.I have a large colorectal polyp that is not on a stalk.
Research Study Groups:
This trial has the following groups:- Group 1: Cold snare & Eleview injection
- Group 2: Hot snare & Placebo injection
- Group 3: Hot snare & Eleview injection
- Group 4: Cold Snare & Placebo injection
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger